Patents by Inventor Taketsugu Seki

Taketsugu Seki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6433167
    Abstract: A triazolo-1,4-diazepine compound having the formula (I): wherein A represents CO, CO—B, or B, B represents a C1 to C6 alkylene group or a C2 to C6 alkylene group having an oxygen atom interposed in the middle thereof, X represents N—O or CH, n represents an integer of 2 to 6, R represents a hydroxyl group, a C1 to C6 lower alkyloxy group or a C1 to C6 lower alkylamino group, provided that these groups may be substituted with an N,N-dimethylamino group, an N,N-diethylamino group, a phenyl group, or a heterocyclic group, and R1 represents a hydrogen atom or a C1 to C3 lower alkyl group having both a PAF antagonistic action and a thromboxane synthesis inhibiting action, and a pharmaceutical composition containing the same as an active ingredient.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: August 13, 2002
    Assignee: Nikken Chemicals Co., Ltd.
    Inventors: Masakazu Fujita, Taketsugu Seki, Haruaki Inada, Tetsuro Sano
  • Patent number: 5843950
    Abstract: A 1,4-dihydropyridine compound having the formula (I): ##STR1## wherein, R.sup.1 indicates --COO--A--(3-pyridyl), A indicates a C.sub.3 -C.sub.6 straight chain alkylene group in which one piperazine may be interposed; R.sup.2 indicates a C.sub.2 -C.sub.10 alkyl group, alkenyl group or alkynyl group; a lower alkyl group or lower alkenyl group having a substituent; or a cycloalkyl group which may have a substituent; R.sup.3 indicates the same group as R.sup.1 or --COO--R.sup.4 ; and R.sup.4 indicates a lower alkyl group which may have a substituent or its pharmacologically acceptable salt and an anti-allergenic drug, antiphlogistic, drug for overcoming resistance to anti-cancer drugs, or drug for reinforcing the effect of anti-cancer drugs containing the same as effective ingredients.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: December 1, 1998
    Assignee: Nikken Chemicals Co., Ltd.
    Inventors: Shigeyuki Tasaka, Teruhisa Miura, Akira Kiue, Taketsugu Seki, Tetsuro Sano, Mie Kamakura, Masakazu Fujita
  • Patent number: 4968708
    Abstract: The present invention relates to novel imidazo-[2,1-b]benzothiazole compounds represented by formula (I) and pharmacological acceptable salts thereof: ##STR1## wherein R.sub.1 represents a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms; R.sub.2 represents a ##STR2## group (wherein X and Y, which may be the same or different, each represents a hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms or a substituted or unsubstituted phenyl group), a --CH.sub.2 --O--Z group (wherein Z represents a lower alkyl group having 1 to 4 carbon atoms or a substituted or unsubstituted benzyl group) or a --CH.sub.2 --O--CO--W group (wherein W represents an alkyl group having 1 to 8 carbon atoms, an alkylamino group having 1 to 8 carbon atoms, a substituted or unsubstituted phenyl group or a thienyl group); and R.sub.3 ; R.sub.4 and R.sub.
    Type: Grant
    Filed: June 21, 1989
    Date of Patent: November 6, 1990
    Assignee: Nikken Chemicals Co., Ltd.
    Inventors: Taketsugu Seki, Shigeyuki Tasaka, Ryuichi Hoshino